CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
with fingolimod in children and adolescents with relapsing-remitting multiple sclerosis aged between 10 and < 18 years over a durat...
Phase 3
Columbus, Ohio, United States and 118 other locations
Open-label study to evaluate the effectiveness of treatment with ofatumumab in subjects transitioning from any fumarate-based RMS approved therapy or...
Phase 3
Westerville, Ohio, United States and 122 other locations
A single arm study evaluating the continued efficacy, safety and tolerability of ofatumumab in patients with relapsing multiple sclerosis...
Phase 3
Westerville, Ohio, United States and 20 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Westerville, Ohio, United States and 208 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Columbus, Ohio, United States and 225 other locations
The primary objectives are to investigate the safety and tolerability of BIIB091 monotherapy in participants with relapsing multiple sclerosis...
Phase 2
Columbus, Ohio, United States of America and 70 other locations
in male and female participants with relapsing forms of multiple sclerosis (aged 18 to 55 years at the time of enrollment). People ...
Phase 3
Columbus, Ohio, United States of America and 34 other locations
The purpose of this randomized, double-blind, placebo-controlled, parallel group study is to determine the efficacy of frexalimab in delaying the dis...
Phase 3
Columbus, Ohio, United States of America and 30 other locations
Primary Objective:To determine the long-term safety and tolerability of SAR442168 in RMS participantsSecondary Objective:To evaluate efficacy of SAR4...
Phase 2
Westerville, Ohio, United States and 36 other locations
The purpose of this study is to evaluate long-term safety and efficacy of ublituximab therapy in participants with relapsing multiple sclerosis...
Phase 3
Columbus, Ohio, United States and 85 other locations
Clinical trials
Research sites
Resources
Legal